AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: GRIESINGER F HANNEMANN P CRIEE CP HEMMERLEIN B DALICHAU H HESS CF WORMANN B SCHMIDBERGER H HERSE B HIDDEMANN W
Citation: F. Griesinger et al., STAGE IIIB NONSMALL CELL LUNG-CANCER - TAXANE CARBOPLATIN (T/C) COMBINATION THERAPY FOR INDUCTION/, Annals of oncology, 9, 1998, pp. 489-489

Authors: HESS CF SCHMIDBERGER H
Citation: Cf. Hess et H. Schmidberger, ADJUVANT RADIOTHERAPY IN THE TREATMENT OF BREAST-CANCER, Anticancer research, 18(3C), 1998, pp. 2213-2214

Authors: LAURENT D PRADIER O SCHMIDBERGER H RAVEFRANK M FRANKENBERG D HESS CF
Citation: D. Laurent et al., RADIATION RENDERED MORE CYTOTOXIC BY FLUDARABINE MONOPHOSPHATE IN A HUMAN OROPHARYNX CARCINOMA CELL-LINE THAN IN FETAL LUNG FIBROBLASTS, Journal of cancer research and clinical oncology, 124(9), 1998, pp. 485-492

Authors: BEHR TM MEMTSOUDIS S SHARKEY RM BLUMENTHAL RD DUNN RM GRATZ S WIELAND E NEBENDAHL K SCHMIDBERGER H GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., EXPERIMENTAL STUDIES ON THE ROLE OF ANTIBODY FRAGMENTS IN CANCER RADIO-IMMUNOTHERAPY - INFLUENCE OF RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY, International journal of cancer, 77(5), 1998, pp. 787-795

Authors: BEHR TM SGOUROS G VOUGIOUKAS V MEMTSOUDIS S GRATZ S SCHMIDBERGER H BLUMENTHAL RD GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., THERAPEUTIC EFFICACY AND DOSE-LIMITING TOXICITY OF AUGER-ELECTRON VS.BETA-EMITTER IN RADIOIMMUNOTHERAPY WITH INTERNALIZING ANTIBODIES - EVALUATION OF I-125-LABELED VS I-131-LABELED CO17-1A IN A HUMAN COLORECTAL-CANCER MODEL, International journal of cancer, 76(5), 1998, pp. 738-748

Authors: CLASSEN J SCHMIDBERGER H SOUCHON R BAMBERG M
Citation: J. Classen et al., EARLY-STAGE TESTICULAR SEMINOMA - A PROSPECTIVE MULTICENTER TRIAL, European journal of cancer, 33, 1997, pp. 154-154

Authors: GRIESINGER F KERN W BINDER L HANNEMANN P CRIEE CP HEMMERLEIN B HESS CF WORMANN B SCHMIDBERGER H HERSE B HIDDEMANN W
Citation: F. Griesinger et al., PHASE-II STUDY OF TAXOTERE CARBOPLATIN WITH PHARMACOKINETICS AND PHARMACODYNAMICS IN NSCLC FOR DOWNSTAGING IN STAGE-III B AND PALLIATION INSTAGE-IV/, European journal of cancer, 33, 1997, pp. 1050-1050

Authors: SCHMIDBERGER H BAMBERG M MEISNER C CLASSEN J WINKLER C HARTMANN M TEMPLIN R WIEGEL T DORNOFF W ROSS D THIEL HJ MARTINI C HAASE W
Citation: H. Schmidberger et al., RADIOTHERAPY IN STAGE IIA AND IIB TESTICULAR SEMINOMA WITH REDUCED PORTALS - A PROSPECTIVE MULTICENTER STUDY, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 321-326

Authors: HOFFMANN W BELKA C SCHMIDBERGER H BUDACH W BOCHTLER H HESS CF BAMBERG M
Citation: W. Hoffmann et al., RADIOTHERAPY AND CONCOMITANT WEEKLY 1-HOUR INFUSION OF PACLITAXEL IN THE TREATMENT OF HEAD AND NECK-CANCER - RESULTS FROM A PHASE-I TRIAL, International journal of radiation oncology, biology, physics, 38(4), 1997, pp. 691-696

Authors: HOFFMANN W RODEMANN HP BELKA C BUDACH W SCHMIDBERGER H BOCHTLER H HEINRICH V BAMBERG M
Citation: W. Hoffmann et al., PACLITAXEL IN SIMULTANEOUS RADIOCHEMOTHERAPY OF HEAD AND NECK-CANCER - PRECLINICAL AND CLINICAL-RESULTS, Seminars in oncology, 24(1), 1997, pp. 72-77

Authors: SCHMIDBERGER H RAVEFRAENK M SCHWEINFURTH S REHRING E HESS CF
Citation: H. Schmidberger et al., THE COMBINED EFFECT OF INTERFERON-BETA AND RADIATION ON VARIOUS HUMANTUMOR-CELL LINES AND EMBRYONAL LUNG FIBROBLASTS, Radiology, 205, 1997, pp. 721-721

Authors: VIRSIKPEUCKERT P RAVEFRANK M LANGEBRAKE U SCHMIDBERGER H
Citation: P. Virsikpeuckert et al., DIFFERENCES IN THE YIELDS OF DICENTRICS AND RECIPROCAL TRANSLOCATIONSOBSERVED IN THE CHROMOSOMES OF IRRADIATED HUMAN SKIN FIBROBLASTS AND BLOOD-LYMPHOCYTES FROM THE SAME HEALTHY-INDIVIDUALS, Radiation research, 148(3), 1997, pp. 209-215

Authors: BEHR TM WULST E RADETZKY S BLUMENTHAL RD DUNN RM GRATZ S RAVEFRANK M SCHMIDBERGER H RAUE F BECKER W
Citation: Tm. Behr et al., IMPROVED TREATMENT OF MEDULLARY-THYROID CANCER IN A NUDE-MOUSE MODEL BY COMBINED RADIOIMMUNOCHEMOTHERAPY - DOXORUBICIN POTENTIATES THE THERAPEUTIC EFFICACY OF RADIOLABELED ANTIBODIES IN A RADIORESISTANT TUMOR TYPE, Cancer research, 57(23), 1997, pp. 5309-5319

Authors: EINSELE H BAMBERG M BUDACH H SCHMIDT H SCHMIDBERGER H HEBART H TRUMPER L LOFFLER B SCHLIMOK G HERTENSTEIN B METZNER B FRICKHOFEN N FAUL C BRUGGER W KANZ L
Citation: H. Einsele et al., TOTAL MARROW IRRADIATION, BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY PERIPHERAL AUTOLOGOUS PBSCT IN PATIENTS WITH ADVANCED MULTIPLE-MYELOMA, Blood, 90(10), 1997, pp. 489-489

Authors: RAVEFRANK M VIRSIKPEUCKERT P BERTRAM K SCHMIDBERGER H
Citation: M. Ravefrank et al., CHROMOSOME ANALYSIS IN X-IRRADIATED PRIMARY-CELLS OF A HUMAN SQUAMOUS-CELL CARCINOMA BY FLUORESCENCE IN-SITU HYBRIDIZATION, International journal of radiation biology, 69(6), 1996, pp. 695-700

Authors: LAURENT D SCHMIDBERGER H PRADIER O HESS CF
Citation: D. Laurent et al., FACIAL ANGIOEDEMA ASSOCIATED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) TREATMENT, Onkologie, 19(5), 1996, pp. 444-445

Authors: KORTMANN RD HESS CF MEISNER C SCHMIDBERGER H BAMBERG M
Citation: Rd. Kortmann et al., ACCURACY OF FIELD ALIGNMENT IN ABDOMINAL RADIATION-THERAPY, International journal of radiation oncology, biology, physics, 35(4), 1996, pp. 779-783

Authors: EINSELE H BAMBERG M SCHMIDBERGER H SCHMIDT H HEBART H FAUL C WEISS B BRUGGER W KANZ L
Citation: H. Einsele et al., A PHASE I II TRIAL OF TOTAL MARROW IRRADIATION, BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED MULTIPLE-MYELOMA/, Experimental hematology, 24(9), 1996, pp. 707-707

Authors: VIRSIKPEUCKERT P RAVEFRANK M SCHMIDBERGER H
Citation: P. Virsikpeuckert et al., FURTHER-STUDIES ON THE POSSIBLE RELATIONSHIP BETWEEN RADIATION-INDUCED RECIPROCAL TRANSLOCATIONS AND INTRINSIC RADIOSENSITIVITY OF HUMAN TUMOR-CELLS, Radiotherapy and oncology, 40(2), 1996, pp. 111-119

Authors: RAVEFRANK M VIRSIKPEUCKERT P SCHMIDBERGER H RODEMANN HP
Citation: M. Ravefrank et al., RECIPROCAL TRANSLOCATION FREQUENCY IN IRRADIATED SENSITIVE AND RESISTANT HUMAN TUMOR-CELLS IN CORRELATION WITH CLONOGENIC IN-VITRO CELL-SURVIVAL - A POSSIBILITY OF TUMOR RADIOSENSITIVITY PREDICTION, Radiotherapy and oncology, 38(2), 1996, pp. 163-170

Authors: EINSELE H BAMBERG M SCHMIDBERGER H SCHMIDT H HEBART H ZANDER A TRUMPER L LOFFLER B SCHUMACHER K HOFFMAN A SCHLIMOK G HERTENSTEIN B GANSER A METZNER B FRICKHOFEN N FAUL C
Citation: H. Einsele et al., A PHASE I II TRIAL OF TOTAL MARROW IRRADIATION, BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED MULTIPLE-MYELOMA/, Blood, 88(10), 1996, pp. 518-518

Authors: RAVEFRANK M VIRSIKPEUKERT P SCHMIDBERGER H HESS CF
Citation: M. Ravefrank et al., COMPARISON OF RADIATION-INDUCED TRANSLOCATIONS IN EARLY AND LATE PASSAGE TUMOR-CELLS BY FISH, European journal of cancer, 31A, 1995, pp. 837-837

Authors: WEISS E SCHMIDBERGER H JANY R HESS CF BAMBERG M
Citation: E. Weiss et al., PALLIATIVE RADIOTHERAPY OF MUCOCUTANEOUS LESIONS IN MALIGNANT ACANTHOSIS NIGRICANS, Acta oncologica, 34(2), 1995, pp. 265-267

Authors: HESS CF KORTMANN RD SCHMIDBERGER H BAMBERG M
Citation: Cf. Hess et al., HOW RELEVANT IS SECONDARY LEUKEMIA FOR INITIAL TREATMENT SELECTION INHODGKINS-DISEASE, European journal of cancer, 30A(10), 1994, pp. 1441-1447

Authors: HESS CF KORTMANN RD SCHMIDBERGER H BAMBERG M
Citation: Cf. Hess et al., HOW RELEVANT IS SECONDARY LEUKEMIA FOR INITIAL TREATMENT SELECTION INHODGKINS-DISEASE, European journal of cancer, 30A(10), 1994, pp. 1441-1447
Risultati: 1-25 | 26-28